As businesses feel the lingering stress from the COVID-19 pandemic, some are considering bringing patent prosecution in-house in order to cut costs. With clients continuing to mind their budgets, how can firms demonstrate the cost savings and ROI they bring to the table?

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.

Driven by market demand for efficiencies and cost savings, law firms and IP departments are looking to implement more legal technology into their workflow. But after all the work you put into choosing the right tool, how do you get attorneys and staff members to adopt?

Executives at T-Mobile may be weighing a potential merger with Comcast, the largest U.S. cable provider. 

Fiat Chrysler and Peugeot owner PSA Group recently announced the terms of a $48 billion merger that would create the world's fourth-largest automaker. A primary reason for the merger is to share the cost of developing electric and autonomous vehicles.

Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.

United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019. 

Sprint and T-Mobile recently announced that they had reached a deal to merge, promising to “be a force for positive change in the U.S. wireless, video, and broadband industries.” Combining the country’s third and fourth largest mobile service providers would be one of the most significant consolidations in the American wireless market in years.

Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.

On Sunday, February 24, film fans, pop culture fanatics, and all of Hollywood’s brightest stars will tune in to the live broadcast of the 91st Oscars ceremony. With eight movies nominated for best picture, from the bombastic Queen biopic Bohemian Rhapsody to the devastatingly poetic Roma, the ceremony is guaranteed to be star-studded, ornate, and maybe even a little unpredictable.